Dice Therapeutics

Acquired

South San Francisco, United States · Founded 2013 · $60.0M raised

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$60.0M
Last Round
$60.0M Series CAug 2021
Rounds
2
Acquisition Date
Jun 2023

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 7 investors for this company. The full record is or through the API.

About

DICE Therapeutics was a clinical-stage biopharmaceutical company based in South San Francisco, California, focused on discovering and developing oral small molecule therapies that target protein-protein interactions — a class of targets traditionally considered undruggable. Founded in 2013 by CEO Kevin Judice and Phil Patten, DICE developed its proprietary DC Platform to identify small molecules capable of modulating large and complex protein interfaces with high selectivity. The company was acquired by Eli Lilly in 2023.

Summary

Dice Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2013. It has raised $60.0M in total across 2 rounds, most recently a $60.0M Series C round in Aug 2021. Investors include Eli Lilly, RA Capital Management and Sands Capital.

Funding & Exit History

AcquisitionJun 2023

Sign up to see all 4 events

Funding: Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dice Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/dice-therapeutics"><img src="https://indexed.vc/api/badge/company/dice-therapeutics" alt="Dice Therapeutics on Indexed.vc" width="260" height="76" /></a>